MichaelOKochMDFACS

Urology • Indianapolis, IN

Surgical Oncology

Chairman and Professor of Urology Indiana University School of Medicine

Join to view full profile

Dr. Koch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Koch's full profile

Already have an account?

Office
535 Barnhill Dr
# ROUTE420
Indianapolis, IN 46202
Phone+1 317-944-7338

Fax+1 317-278-0499

Education & Training

Vanderbilt University Medical CenterResidency, Urology, 1984 - 1987
Dartmouth-Hitchcock Medical Center1984
Geisel School of Medicine at DartmouthClass of 1981

Certifications & Licensure

IN State Medical License 1998 - 2025
TN State Medical License 1986 - 1999
American Board of Urology Urology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2011-2015
America's Top Doctors for Cancer Castle Connolly, 2010-2015
Indianapolis Monthly Castle Connolly, 2007, 2009-2014

Clinical Trials

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence Start of enrollment: 1999 Jun 14
Terminated
Phase 3
High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer Start of enrollment: 2001 Oct 01
Completed
Phase 1
Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate Start of enrollment: 2001 Oct 01
Completed
Phase 1
A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy Start of enrollment: 2009 Mar 01
Completed
Phase 4
A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial) Start of enrollment: 2008 Jul 01
Active, not recruiting
Not Applicable
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer ...
Clinton D Bahler, Isamu Tachibana, Mark Tann, Katrina Collins, Jordan K Swensson
The Journal of Urology. 2024-08-01
14 citations
Prostate Specific Membrane Antigen Targeted Positron Emission Tomography of Primary Prostate Cancer: Assessing Accuracy with Whole Mount Pathology
Clinton D. Bahler, Mark A. Green, Gary D. Hutchins, Liang Cheng, Martin J. Magers
The Journal of Urology. 2020-01-01
23 citations
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer
Laurence Klotz, Christian P. Pavlovich, Joseph L. Chin, Gencay Hatiboglu, Michael O. Koch
The Journal of Urology. 2021-03-01

Journal Articles

A Parallel Randomized Clinical Trial Examining the Return of Urinary Continence After Robot-Assisted Radical Prostatectomy with or Without a Small Intestinal Submucosa...
Naveen Kella, Michelle A Boger, Michael O Koch, Steven M Lucas, Chandru P Sundaram, Clinton D Bahler, Thomas A Gardner, The Journal of Urology

Lectures

AUA Education Workshop for Program Directors and Chairpersons
American Urological Association, Linthicum, Maryland - 2/9/2013

Authored Content

Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future PerspectivesSeptember 2018

Press Mentions

Illuccix Approved by FDA as Prostate Cancer Imaging AgentApril 15th, 2022
First Patients Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging AgentApril 14th, 2022
The End to WHAT Controversy?June 24th, 2016
Join now to see all

Professional Memberships

Alpha Omega Alpha Honor Medical Society - AOA
Member
American Urological Association - AUA
Member